Recursion Reports Fourth Quarter and Full Year 2025 Financial Results ...
Dec 31, 2025 · “Recursion has reached an inflection point: moving from proving that AI can participate in drug discovery to demonstrating that an AI-native operating system can generate clinical proof and …
Recursion Reports Third Quarter 2025 Financial Results and Provides ...
Oct 9, 2025 · Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New York, London, …
Pioneering AI Drug Discovery | Recursion
All of our results feed back into our drug discovery and drug development platform – the Recursion Operating System – in a continuously improving feedback loop.
Our Unique Approach to AI Drug Discovery | Recursion
Delve into Recursion's unique TechBio approach. Discover how we're revolutionizing AI drug discovery and the biotech industry. Read more about our approach today!
Recursion Pharmaceuticals, Inc. - Recursion and Exscientia Enter ...
Aug 8, 2024 · Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, Montreal, the San …
Recursion Pharmaceuticals, Inc. - Recursion to Present at 44th Annual J ...
Jan 6, 2026 · Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New York, London, …
Recursion's Drug Discovery Pipeline | Recursion
Leveraging the power of the Recursion OS, we are building an industry-leading pipeline of potential best-in-class and first-in-class therapeutic assets. We focus on indications with high unmet need, …
Recursion OS:
By leveraging Recursion’s vast data universe and machine learning models at every stage of the discovery, design and delivery process, we are able to rapidly validate and accelerate high-potential …
How a First-of-its-Kind “Microglia Map” from Recursion and Roche and ...
Oct 29, 2025 · A first-of-its-kind whole genome map from researchers at Recursion with partners Roche and Genentech offers a new approach to exploring novel targets and pathways for a wide range of …
Recursion Pharmaceuticals, Inc.
Recursion Pharmaceuticals, Inc.